A detailed history of Mayfair Advisory Group, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mayfair Advisory Group, LLC holds 4,992 shares of MRK stock, worth $635,481. This represents 0.48% of its overall portfolio holdings.

Number of Shares
4,992
Previous 4,844 3.06%
Holding current value
$635,481
Previous $528,000 24.62%
% of portfolio
0.48%
Previous 0.45%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$113.24 - $131.95 $16,759 - $19,528
148 Added 3.06%
4,992 $658,000
Q4 2023

Jan 19, 2024

BUY
$100.18 - $109.02 $20,036 - $21,804
200 Added 4.31%
4,844 $528,000
Q3 2023

Oct 23, 2023

BUY
$102.95 - $114.33 $56,622 - $62,881
550 Added 13.43%
4,644 $478,000
Q4 2022

Jan 27, 2023

SELL
$87.44 - $112.11 $21,073 - $27,018
-241 Reduced 5.56%
4,094 $0
Q3 2022

Nov 08, 2022

BUY
$84.53 - $94.96 $65,679 - $73,783
777 Added 21.84%
4,335 $380,000
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $10,102 - $11,451
121 Added 3.52%
3,558 $318,000
Q1 2022

Apr 14, 2022

BUY
$73.51 - $82.4 $25,581 - $28,675
348 Added 11.27%
3,437 $287,000
Q4 2021

Jan 19, 2022

BUY
$72.28 - $90.54 $1,011 - $1,267
14 Added 0.46%
3,089 $244,000
Q3 2021

Oct 08, 2021

BUY
$71.68 - $78.83 $17,920 - $19,707
250 Added 8.85%
3,075 $256,000
Q2 2021

Jul 29, 2021

BUY
$70.31 - $77.77 $3,515 - $3,888
50 Added 1.8%
2,825 $220,000
Q1 2021

Apr 19, 2021

SELL
$68.86 - $81.11 $49,579 - $58,399
-720 Reduced 20.6%
2,775 $214,000
Q4 2020

Jan 28, 2021

SELL
$71.77 - $79.65 $1,148 - $1,274
-16 Reduced 0.46%
3,495 $286,000
Q3 2020

Oct 26, 2020

BUY
$73.18 - $82.95 $41,785 - $47,364
571 Added 19.42%
3,511 $291,000
Q2 2020

Jul 13, 2020

BUY
$70.42 - $80.13 $207,034 - $235,582
2,940 New
2,940 $227,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $322B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mayfair Advisory Group, LLC Portfolio

Follow Mayfair Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mayfair Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mayfair Advisory Group, LLC with notifications on news.